NBC Securities Inc. lifted its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 137,400.0% in the first quarter, according to the company in its most recent filing with the ...

This rally in Illumina proved a shot in the arm for one of the most Illumina-sensitive funds, the ARK Genomic Revolution ETF (BATS:ARKG). It surged about 4% this week to outperform broader biotech ...

On Thursday, Jan. 22, 2026, Cathie Wood-led Ark Invest bought $2.4 million in Tempus AI and WeRide while selling $1.6 million ...

The ARK Genomic Revolution ETF remains a "Buy" as it beats SPY/XLV, shows bullish breakout signals, and targets $42. Learn more about the fund.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...